RecruitingPhase 1NCT05067387

Evaluation of Oral THC and CBD in Men and Women

Evaluation of Oral THC and CBD in Oral Fluid, Pharmacokinetics, and Subjective and Neurocognitive Effects in Men and Women

Sponsor

University of California, Los Angeles

Enrollment

22 participants

Start Date

Aug 13, 2026

Study Type

INTERVENTIONAL

Conditions

Drug Abuse Intoxication by Drug Impairment

Summary

The purpose of this study is to determine the pharmacokinetics and pharmacodynamics of oral delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) and to evaluate detection of recently smoked THC in oral fluid.

Eligibility

Min Age: 21 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called CBD, a drug called Placebo, and others for people with drug abuse, impairment, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years to 55 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.